Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment. (Q63570916)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment. |
clinical trial |
Statements
CONPET (English)
0 references
KRd Consolidation in Myeloma Patients With a Positive PET-CT After Standard First Line Treatment. A Phase II Study (English)
0 references
16 March 2018
0 references
March 2020
0 references
50
0 references
18 year
0 references